Avid Bioservices Stock (NASDAQ: CDMO) stock price, news, charts, stock research, profile.
You can purchase shares of Avid Bioservices (NASDAQ:CDMO) through any online brokerage.
Other companies in Avid Bioservices’s space includes: Immunome (NASDAQ:IMNM), 89bio (NASDAQ:ETNB), Gyre Therapeutics (NASDAQ:GYRE), Cogent Biosciences (NASDAQ:COGT) and Replimune Group (NASDAQ:REPL).
Avid Bioservices has a consensus price target of $13.63.
The stock price for Avid Bioservices (NASDAQ: CDMO) is $12.4101 last updated January 22, 2025 at 6:55 PM EST.
There are no upcoming dividends for Avid Bioservices.
Avid Bioservices’s Q3 earnings are confirmed for Wednesday, April 23, 2025.
There is no upcoming split for Avid Bioservices.
Avid Bioservices is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.